Leptin, a pleiotropic adipokine, crosses the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) from the periphery and facilitates experimental autoimmune encephalomyelitis (EAE). EAE induces dynamic changes of leptin receptors in enriched brain and spinal cord microvessels, leading to further questions about the potential roles of endothelial leptin signaling in EAE progression. In endothelial leptin receptor specific knockout (ELKO) mice, there were lower EAE behavioral scores in the early phase of the disorder, better preserved BSCB function shown by reduced uptake of sodium fluorescein and leukocyte infiltration into the spinal cord. Flow cytometry showed that the ELKO mutation decreased the number of CD3 and CD45 cells in the spinal cord, although immune cell profiles in peripheral organs were unchanged. Not only were CD4 + and CD8 + T lymphocytes reduced, there were also lower numbers of CD11b + Gr1 + granulocytes in the spinal cord of ELKO mice. In enriched microvessels from the spinal cord of the ELKO mice, the decreased expression of mRNAs for a few tight junction proteins was less pronounced in ELKO than WT mice, as was the elevation of mRNA for CCL5, CXCL9, IFN-c, and TNF-a. Altogether, ELKO mice show reduced inflammation at the level of the BSCB, less leukocyte infiltration, and better preserved tight junction protein expression and BBB function than WT mice after EAE. Although leptin concentrations were high in ELKO mice and microvascular leptin receptors show an initial elevation before inhibition during the course of EAE, removal of leptin signaling helped to reduce disease burden. We conclude that endothelial leptin signaling exacerbates BBB dysfunction to worsen EAE.
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Introduction
Leptin, a 16 kD soluble protein produced mainly by adipocytes, can reach the CNS by specific transport systems at the blood-brain barrier (BBB) and blood-spinal cord barrier (BCSB) (Banks et al., 1996; Pan and Kastin, 2001; Tu et al., 2008) . Leptin is proinflammatory and facilitates autoimmunity. Studies involving leptin treatment, antagonism, and knockout mice have collectively shown that leptin worsens experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS) (Matarese et al., 2001a (Matarese et al., , 2001c Sanna et al., 2003) . In particular, a serum leptin surge precedes the onset of EAE, and leptin-deficient (ob/ob) mice and leptin receptor ObRb-deficient (db/db) mice are resistant to the induction and progression of EAE. Leptin treatment by peripheral delivery increases susceptibility of mice to EAE. In active EAE brain lesions, leptin is also produced by pathogenic T helper (Th1) cells and macrophages (Sanna et al., 2003) . Studies from ob/ob and db/db mice that have defective T cell responses show that leptin stimulates Th1 response but inhibits Th2 response (Lord et al., 1998) . However, astrocyte-specific leptin receptor knockout (ALKO) mice show worsened EAE and greater leukocyte infiltration in spinal cord and brain (Mishra et al., 2013) , indicating a cell-specific leptin action in the CNS.
The BBB and BSCB are three-dimensional, multicellular neurovascular interfaces. The comprising microvascular endothelial cells are joined by tight junction (TJ) complexes. The TJ complex consists of three major classes of transmembrane proteins: occludins, claudins, and junctional adhesion molecules, and it is reinforced by TJassociated adaptor proteins, such as zonula occludin (ZO)-1, ZO-2, and ZO-3 that serve as scaffolding proteins to secure transmembrane TJ protein localization on the membrane (Liebner et al., 2000b; Wolburg and Lippoldt, 2002; Abbott et al., 2010) . Altered expression of occludin, junctional adhesion molecules, and ZO-1 has been documented in acute and progressive forms of MS, together with changes in the vascular basement membrane and pericytes (Kirk et al., 2003; Alvarez et al., 2011 
